Skip to content
healthcare.dev

MOUNJARO

NDC 50090-8021, tirzepatide, injection, solution, from A-S Medication Solutions.

Product NDC
50090-8021
Status
Listed
Labeler
A-S Medication Solutions
Dosage form
INJECTION, SOLUTION
Route
SUBCUTANEOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA215866
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/50090-8021 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • TIRZEPATIDE10 mg/.5mL

Pharmacologic classes

G-Protein-linked Receptor Interactions [MoA]; GLP-1 Receptor Agonist [EPC]; Glucagon-like Peptide-1 (GLP-1) Agonists [MoA]; Glucose-dependent Insulinotropic Polypeptide Receptor Agonist [EPC]

Package NDCNDC-11Package
50090-8021-0500908021004 SYRINGE in 1 CARTON (50090-8021-0) / .5 mL in 1 SYRINGE

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/78aad975-4971-49fa-b4b0-6aa39f76d2e7

Use it

Look up 50090-8021 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/50090-8021 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 50090-8021. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.